There is no commercial support for this activity.

About the speaker

Professor Wexler graduated from Harvard College Magna Cum Laude with a major in Government and earned his MD at Albert Einstein of Medicine where he did research on neurotransmitter synthesis in cell cultures, studied for two years with Oliver Sacks, and studied psychiatry at Anna Freud’s clinic in Hampstead and neurology at the Institute of Neurology, Queen Square. He trained in psychiatry at Yale University and stayed as a member of the faculty. He argued for the importance of a neurosystems view of normal and abnormal brain function in a 1986 lead paper in the British Journal of Psychiatry, anticipated RDoC in a 1992 Biological Psychiatry paper advocating use of multiple physiological and cognitive measures to move past rather than hope to confirm psychiatry’s 100 year-old diagnostic system, and helped launch the field of digital neurotherapy with a series of intervention and fMRI studies beginning in 1997. This led to new, physiologically-based, technology-enabled, non-pharmacologic treatments for depression and ADHD, programs used in schools to enhance development of cognitive functions necessary for learning and compromised by poverty, and an NIH Director’s Award for paradigm-changing medical research. In 2006, Professor Wexler published Brain and Culture: Neurobiology, Ideology and Social Change (MIT press), a seminal text in cultural neuroscience. He has published over 135 peer-reviewed scientific papers and given invited lectures in North and South America, Europe and Asia.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt Health System, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Bruce E. Wexler, MD, reports that he is a consultant and equity holder in C8Sciences. He will be discussing research on commercial digital neurotherapies. All of the relevant financial relationships for Dr. Wexler have been mitigated through review. 

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Elizabeth Ryznar, MD, MSc, Louis J. Marino, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.